1. Home
  2. RAPP vs BHVN Comparison

RAPP vs BHVN Comparison

Compare RAPP & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$26.92

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.04

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
BHVN
Founded
2022
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
RAPP
BHVN
Price
$26.92
$13.04
Analyst Decision
Strong Buy
Buy
Analyst Count
5
15
Target Price
$47.80
$29.43
AVG Volume (30 Days)
427.2K
3.7M
Earning Date
11-06-2025
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$7.48
52 Week High
$42.27
$44.28

Technical Indicators

Market Signals
Indicator
RAPP
BHVN
Relative Strength Index (RSI) 42.60 62.98
Support Level $26.30 $10.35
Resistance Level $28.10 $12.87
Average True Range (ATR) 1.80 1.25
MACD -0.37 0.20
Stochastic Oscillator 20.07 96.61

Price Performance

Historical Comparison
RAPP
BHVN

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: